1.Clinical constellation of annular erythema associated with anti-Ro/La autoantibodies.
Journal of Korean Medical Science 2000;15(2):199-202
Annular erythema (AE) associated with anti-Ro (SSA) and/or La (SSB) autoantibody in patients with Sjogren syndrome (SS) or with SS/systemic lupus erythematosus overlap syndrome (SS/SLE), has recently been described in Orientals, and it may be a counterpart of annular skin lesion of the subacute cutaneous LE seen mostly in Caucasians. The author examined five Korean AE patients in respect to dinical diversity. In this small-sample study, subtle differences appeared between individual cases regarding the serologic features and the diagnoses of the disease. Among the five cases, four had circulating anti-Ro and anti-La antibodies, and one had only anti-La. Regarding the diagnosis, one was SS/SLE, two were primary SS, and the remaining two were only "AE associated with anti-Ro/La antibody". There seem to be a wide clinical spectrum in the disease expression of AE associated with anti-Ro/La autoantibody than previously thought.
Adolescence
;
Adult
;
Antibodies, Antinuclear/immunology*
;
Case Report
;
Erythema/immunology*
;
Erythema/etiology
;
Female
;
Human
;
Lupus Erythematosus, Systemic/immunology*
;
Lupus Erythematosus, Systemic/complications
;
Male
;
Sjogren's Syndrome/immunology*
;
Sjogren's Syndrome/complications
2.Sequential bilateral central retinal artery occlusion as the primary manifestation of systemic lupus erythematosus.
Xuan ZOU ; Yan ZHUANG ; Fang-tian DONG ; Fan ZHANG ; You-xin CHEN
Chinese Medical Journal 2012;125(8):1517-1519
Bilateral central retinal artery occlusion (CRAO) has been rarely reported as the primary manifestation in patients with systemic lupus erythematosus (SLE). The severe retinal vaso-occlusive diseases usually cause devastating and permanent damage to visual function in spite of vigorous treatment. A 42-year-old Chinese woman presented with abrupt bilateral vision loss. The diagnosis of bilateral CRAO was suggested by the ocular presentation and fluorescein angiography. Laboratory studies showed positive results of antinuclear antibody, anti-Ro/SSA anti-La/SSB; decreased levels of C3, C4 complement and normal levels of antiphospholipides antibodies (APAs). Her visual acuity deteriorated despite systemic steroid and immunosuppressant treatment. Severe vaso-occlusive retinopathy may be an earlier manifestation of SLE without elevated level of APAs.
Adult
;
Blindness
;
etiology
;
Female
;
Humans
;
Lupus Erythematosus, Systemic
;
complications
;
drug therapy
;
immunology
;
Retinal Artery Occlusion
;
etiology
4.A Case of Anti-LKM 1 Positive Autoimmune Hepatitis Accompanied by Systemic Lupus Erythematosus.
Dae Han CHOI ; Hae Kyung KIM ; Tae Il PARK ; Byung Min JOHN ; Sung Hwan KANG ; Yoon Serk LEE ; Tae Hyun KIM ; Uh Joo LEE ; Tae Seung LEE ; Gwi Ok YOON
The Korean Journal of Gastroenterology 2008;51(3):190-193
Overlap of autoimmune hepatitis and systemic lupus erythematosus (SLE) is a comparatively rare condition. Although both autoimmune hepatitis and SLE can share common autoimmune features such as polyarthralgia, hypergammaglobulinemia and positive ANA, it has been considered as two different entities. We report a case of anti-LKM1 positive autoimmune hepatitis who developed SLE two years later. The presence of interface hepatitis with lymphoplasma cell infiltrates and rosette formation points to the autoimmune hepatitis rather than SLE hepatitis. Autoimmune hepatitis is infrequently accompanied by SLE, therefore, it could be recommended to investigate for SLE in patients with autoimmune hepatitis.
Antibodies, Antinuclear/analysis
;
Autoantibodies/*analysis
;
Echocardiography
;
Female
;
Hepatitis, Autoimmune/complications/*diagnosis/immunology
;
Humans
;
Liver/pathology
;
Lupus Erythematosus, Systemic/complications/*diagnosis/immunology
;
Young Adult
5.2007 Changsha International Symposium on Lupus.
Chinese Medical Journal 2007;120(16):1471-1472
6.Echocardiographic changes and anticardiolipin antibodies in patients with systemic lupus erythematosus.
Sai-dan ZHANG ; Miao WU ; Feng CHEN ; Xiao-xia ZUO ; Jing ZHANG
Journal of Central South University(Medical Sciences) 2006;31(5):692-695
OBJECTIVE:
To analyze the echocardiographic abnormalities and the prevalence of anticardiolipin antibodies (aCL) in systemic lupus erythematosus (SLE) patients and to evaluate the relationship between aCL and cardiac valvular abnormalities in SLE patients.
METHODS:
Ninety SLE patients were performed M-mode, 2-dimensional and Doppler echocardiography and aCL IgG and IgM were measured by an enzyme-linked immunosorbent assay (ELISA). According to the abnormalities in the echocardiography, the patients were assigned into valvular abnormality group and non-valvular abnormality group. Chi-square method was used to compare the difference of aCL prevalence between the two groups.
RESULTS:
The prevalence of echocardiographic abnormalities was 53.33%, and valvular abnormality (38.89%) and pericardial effusion (34.44%) presented most frequently. The aCL prevalence was 32.56% in the 43 SLE patients. The prevalence of aCL in the valvular abnormality group was significantly higher than that in non-valvular abnormality group (52.94% vs 19.23%, P<0.05).
CONCLUSION
The incidence of echocardiographic abnormalities is high in SLE patients, most often in valves and pericardium. The aCL is probably related to valvular damage in SLE patients.
Adolescent
;
Adult
;
Antibodies, Anticardiolipin
;
blood
;
Echocardiography, Doppler
;
Female
;
Heart Valve Diseases
;
etiology
;
immunology
;
physiopathology
;
Humans
;
Lupus Erythematosus, Systemic
;
complications
;
immunology
;
physiopathology
;
Male
7.Autoimmune diseases and fungal infections: immunological mechanisms and therapeutic approaches.
Chinese Medical Journal 2009;122(5):483-485
Candidiasis
;
drug therapy
;
immunology
;
metabolism
;
Diabetes Mellitus, Type 1
;
complications
;
drug therapy
;
immunology
;
therapy
;
Humans
;
Lupus Erythematosus, Systemic
;
drug therapy
;
immunology
;
metabolism
;
Mycoses
;
complications
;
immunology
;
therapy
;
Paraneoplastic Syndromes
;
drug therapy
;
immunology
;
metabolism
;
Pemphigus
;
drug therapy
;
immunology
;
metabolism
8.Cold haemagglutinin disease in systemic lupus erythematosus.
Krishnakumar NAIR ; Keechilat PAVITHRAN ; Joy PHILIP ; Mathew THOMAS ; Vasu GEETHA
Yonsei Medical Journal 1997;38(4):233-235
A 34-year-old lady presenting with features of cold agglutinin disease during the course of systemic lupus erythematosus is described. Cold antibody titer was very high (1 in 4096) with specificity for 'I' antigen. Even though she had poor prognostic factors like high titer of cold antibodies with low thermal amplitude, she responded well to prednisolone.
Adult
;
Anemia, Hemolytic, Autoimmune/immunology
;
Anemia, Hemolytic, Autoimmune/etiology*
;
Anemia, Hemolytic, Autoimmune/drug therapy
;
Antibodies/analysis
;
Case Report
;
Female
;
Human
;
Lupus Erythematosus, Systemic/complications*
;
Prednisolone/therapeutic use
;
Prognosis
9.Clinical and immunopathological features of patients with lupus hepatitis.
Ru-Hua ZHENG ; Jin-Hui WANG ; Shu-Bing WANG ; Jie CHEN ; Wei-Ming GUAN ; Min-Hu CHEN
Chinese Medical Journal 2013;126(2):260-266
BACKGROUNDLupus hepatitis is yet to be characterized based on its clinical features and is often difficult to differentially diagnose from other liver diseases. We aimed to elucidate clinical, histopathological and immunopathological features of lupus hepatitis and to evaluate primarily the effectiveness of liver immunopathological manifestations on differential diagnosis of lupus hepatitis from other liver diseases.
METHODSA retrospective study was performed to analyze clinical features of lupus hepatitis in 47 patients out of 504 inpatients with systemic lupus erythematosus (SLE) in First Affiliated Hospital of Sun Yat-sen University, China from May 2006 to July 2009, and to evaluate the association between lupus hepatitis and SLE activity. Additionally, liver histopathological changes by hematoxylin and eosin (HE) staining and immunopathological changes by direct immunofluorescence test in 10 lupus hepatitis cases were analyzed and compared to those in 16 patients with other liver diseases in a prospective study.
RESULTSOf 504 SLE patients, 47 patients (9.3%) were diagnosed to have lupus hepatitis. The prevalence of lupus hepatitis in patients with active SLE was higher than that in those with inactive SLE (11.8% vs. 3.2%, P < 0.05). The incidence of hematological abnormalities in patients with lupus hepatitis was higher than that in those without lupus hepatitis (40.4% vs. 21.7%, P < 0.05), such as leucocytes count (2.92×10(9)/L vs. 5.48×10(9)/L), platelets count (151×10(9)/L vs. 190×10(9)/L), serum C3 and C4 (0.34 g/L vs. 0.53 g/L; 0.06 g/L vs. 0.09 g/L) (P < 0.05); 45 of 47 (95.7%) lupus hepatitis patients showed 1 upper limit of normal (ULN) < serum ALT level < 5 ULN. The liver histopathological features in patients with lupus hepatitis were miscellaneous and non-specific, similar to those in other liver diseases, but liver immunopathological features showed positive intense deposits of complement 1q in 7/10 patients with lupus hepatitis and negative complement 1q deposits in all patients with other liver diseases (Fisher's exact test, P = 0.011).
CONCLUSIONSLupus hepatitis was not infrequent in active SLE patients which would be one of the indices indicating SLE activity. Positive intense deposit of complement 1q in liver may be a characteristic immunopathological feature of lupus hepatitis, which provides a new way to differentially diagnose lupus hepatitis from other liver diseases.
Adolescent ; Adult ; Aged ; Child ; Cohort Studies ; Complement C1q ; analysis ; Female ; Hepatitis, Autoimmune ; etiology ; immunology ; pathology ; Humans ; Liver ; pathology ; Lupus Erythematosus, Systemic ; complications ; Male ; Middle Aged ; Retrospective Studies
10.Prognosis of Neonates in Pregnant Women with Systemic Lupus Erythematosus.
Yonsei Medical Journal 2008;49(4):515-520
PURPOSE: The effects of maternal systemic lupus erythematosus (SLE) on neonatal prognosis were examined by comparing clinical features of full-term babies born to lupus mothers and age- and parity-matched controls. PATIENTS and METHODS: From January 2000 to December 2005, 39 singletons were born to 37 SLE women. Excluding 11 cases of prematurity and preeclampsia, 28 full-term neonates formed the lupus group. The control group included 66 full-term babies. The retrospective study examined medical records and compared gestational age, birth weight, days of hospital stay, small for gestational age (SGA) frequency, Apgar scores < 7, and parity. Lupus neonates were tested for anti-nuclear antibody (ANA) and platelet count, and electrocardiogram was performed. RESULTS: Average gestational age (38 vs. 39 weeks, p < 0.05) and birth weight (2,775 vs. 3,263g, p < 0.05) were significantly different between the SLE and control groups. SGA frequency was higher in the SLE group (25% vs. 4.5%, p < 0.05). No significant difference was observed in Apgar score, birth weight, gestational age, SGA frequency, and platelet count between lupus subgroups formed based on anti-dsDNA antibody levels and antiphospholipid antibody status. CONCLUSION: The association of maternal ANAs, antiphospholipid antibodies, and drug history with neonatal prognosis could not be elucidated. However, even in uncomplicated pregnancies, maternal lupus is disadvantageous for gestational age, birth weight, and SGA frequency.
Adult
;
Antibodies, Antinuclear/immunology
;
Antibodies, Antiphospholipid/immunology
;
Disease Susceptibility/immunology/pathology
;
Female
;
Humans
;
Infant, Newborn
;
Lupus Erythematosus, Systemic/*complications/immunology
;
Male
;
Platelet Count
;
Pregnancy
;
*Pregnancy Complications
;
*Pregnancy Outcome
;
Prognosis
;
Risk Factors